BG62154B1 - Средства за лечение на смущения, причинени от неправилнаупотреба на вещества - Google Patents

Средства за лечение на смущения, причинени от неправилнаупотреба на вещества Download PDF

Info

Publication number
BG62154B1
BG62154B1 BG99129A BG9912994A BG62154B1 BG 62154 B1 BG62154 B1 BG 62154B1 BG 99129 A BG99129 A BG 99129A BG 9912994 A BG9912994 A BG 9912994A BG 62154 B1 BG62154 B1 BG 62154B1
Authority
BG
Bulgaria
Prior art keywords
hydrogen
carbon atoms
alkyl
halogen
different
Prior art date
Application number
BG99129A
Other languages
Bulgarian (bg)
English (en)
Other versions
BG99129A (bg
Inventor
Anders Bjoerk
Gunnar Andersson
Original Assignee
Pharmacia & Upjohn Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmacia & Upjohn Ab filed Critical Pharmacia & Upjohn Ab
Publication of BG99129A publication Critical patent/BG99129A/bg
Publication of BG62154B1 publication Critical patent/BG62154B1/bg

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Addiction (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Steroid Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Pyridine Compounds (AREA)
  • Compounds Of Unknown Constitution (AREA)
BG99129A 1992-04-21 1994-10-19 Средства за лечение на смущения, причинени от неправилнаупотреба на вещества BG62154B1 (bg)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE9201239A SE9201239D0 (sv) 1992-04-21 1992-04-21 Agents for treating substance abuse disorders
PCT/SE1993/000339 WO1993020821A1 (en) 1992-04-21 1993-04-19 Agents for treating substance abuse disorders

Publications (2)

Publication Number Publication Date
BG99129A BG99129A (bg) 1995-08-28
BG62154B1 true BG62154B1 (bg) 1999-04-30

Family

ID=20386004

Family Applications (1)

Application Number Title Priority Date Filing Date
BG99129A BG62154B1 (bg) 1992-04-21 1994-10-19 Средства за лечение на смущения, причинени от неправилнаупотреба на вещества

Country Status (26)

Country Link
US (1) US5565455A (ru)
EP (1) EP0637242B1 (ru)
JP (1) JP3245642B2 (ru)
KR (1) KR100321319B1 (ru)
AT (1) ATE184484T1 (ru)
AU (1) AU659941B2 (ru)
BG (1) BG62154B1 (ru)
BR (1) BR9306361A (ru)
CA (1) CA2118512C (ru)
CZ (1) CZ281296B6 (ru)
DE (1) DE69326459T2 (ru)
DK (1) DK0637242T3 (ru)
EE (1) EE02974B1 (ru)
ES (1) ES2139007T3 (ru)
GR (1) GR3032030T3 (ru)
HU (1) HU223463B1 (ru)
IL (1) IL105449A (ru)
NO (2) NO308827B1 (ru)
PH (1) PH31051A (ru)
RO (1) RO117150B1 (ru)
RU (1) RU2126254C1 (ru)
SE (1) SE9201239D0 (ru)
SK (1) SK279940B6 (ru)
UA (1) UA27884C2 (ru)
WO (1) WO1993020821A1 (ru)
ZA (1) ZA932757B (ru)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5316759A (en) * 1986-03-17 1994-05-31 Robert J. Schaap Agonist-antagonist combination to reduce the use of nicotine and other drugs
SE9201956D0 (sv) * 1992-06-25 1992-06-25 Kabi Pharmacia Ab Novel nicotinicacid esters
SE9601708D0 (sv) * 1996-05-06 1996-05-06 Pharmacia Ab Pyridyl- and pyrimidyl-piperazines in the treatment of substance abuse disorders
HU226859B1 (en) 1997-10-27 2009-12-28 Neurosearch As Phenyl- or heteroaryl-homopiperazines, their use and medicaments containing them
US6632823B1 (en) * 1997-12-22 2003-10-14 Merck & Co., Inc. Substituted pyridine compounds useful as modulators of acetylcholine receptors
US6358060B2 (en) 1998-09-03 2002-03-19 Jsr Llc Two-stage transmucosal medicine delivery system for symptom relief
US6344222B1 (en) 1998-09-03 2002-02-05 Jsr Llc Medicated chewing gum delivery system for nicotine
US6090780A (en) * 1999-04-07 2000-07-18 Chandon Prasad Histidyl-proline diketopiperazine and method of use
EP2422772A3 (en) 2002-09-20 2012-04-18 Alpharma, Inc. Sequestering subunit and related compositions and methods
HUE032156T2 (en) 2006-06-19 2017-09-28 Alpharma Pharmaceuticals Llc Pharmaceutical preparations
US8642016B2 (en) 2006-07-21 2014-02-04 Jsrnti, Llc Medicinal delivery system, and related methods
US8623418B2 (en) 2007-12-17 2014-01-07 Alpharma Pharmaceuticals Llc Pharmaceutical composition
BRPI1003506B1 (pt) 2010-09-24 2019-12-03 Ache Int Bvi Ltd composto alquil-piperazino-fenil-4(3h)quinazolinonas e uso do composto alquil-piperazino-fenil-4(3h)quinazolinonas associado aos receptores serotoninérgicos 5-ht1a e 5-ht2a

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2958694A (en) * 1959-06-22 1960-11-01 Janssen Paul Adriaan Jan 1-(aroylalkyl)-4-(2'-pyridyl) piperazines
US2985657A (en) * 1959-10-12 1961-05-23 Paul A J Janssen 1-(aroylalkyl)-4-heterocyclylpiperazines
US2979508A (en) * 1959-10-12 1961-04-11 Paul A J Janssen Heterocyclic derivatives of 1-phenyl-omega-(piperazine) alkanols
NO154582C (no) * 1978-10-20 1986-11-05 Ferrosan Ab Analogifremgangsmaate for fremstilling av terapeutisk aktive difenyl-dibutylpiperazinkarboksamider.
US4605655A (en) * 1984-03-06 1986-08-12 Bristol-Myers Company Antipsychotic 1-fluorophenylbutyl-4-(2-pyrimidinyl)piperazine derivatives
US4766215A (en) * 1987-02-27 1988-08-23 American Home Products Corporation Histamine H1 -receptor antagonists
SE8701375D0 (sv) * 1987-04-02 1987-04-02 Leo Ab Novel pyridyl- and pyrimidyl derivatives
US5217987A (en) * 1989-10-30 1993-06-08 Berger Stephen P Dopamine uptake inhibitors in reducing substance abuse and/or craving
SE9100860D0 (sv) * 1991-03-22 1991-03-22 Kabi Pharmacia Ab New use

Also Published As

Publication number Publication date
AU659941B2 (en) 1995-06-01
NO20004169D0 (no) 2000-08-21
SK279940B6 (sk) 1999-06-11
EP0637242A1 (en) 1995-02-08
IL105449A (en) 1998-02-22
SK126994A3 (en) 1995-07-11
DK0637242T3 (da) 2000-03-27
DE69326459T2 (de) 2000-03-23
ATE184484T1 (de) 1999-10-15
HU223463B1 (hu) 2004-07-28
WO1993020821A1 (en) 1993-10-28
RO117150B1 (ro) 2001-11-30
NO318461B1 (no) 2005-03-21
CA2118512C (en) 2004-07-27
ES2139007T3 (es) 2000-02-01
SE9201239D0 (sv) 1992-04-21
NO20004169L (no) 1994-10-20
BR9306361A (pt) 1998-06-30
NO308827B1 (no) 2000-11-06
RU94045866A (ru) 1996-10-20
KR950701221A (ko) 1995-03-23
KR100321319B1 (ko) 2002-07-27
RU2126254C1 (ru) 1999-02-20
UA27884C2 (uk) 2000-10-16
NO943977L (no) 1994-10-20
CZ281296B6 (cs) 1996-08-14
AU4043793A (en) 1993-11-18
NO943977D0 (no) 1994-10-20
JP3245642B2 (ja) 2002-01-15
HUT71420A (en) 1995-11-28
ZA932757B (en) 1993-10-28
HU9403020D0 (en) 1994-12-28
EP0637242B1 (en) 1999-09-15
PH31051A (en) 1998-02-03
CA2118512A1 (en) 1993-10-28
CZ260694A3 (en) 1995-09-13
DE69326459D1 (de) 1999-10-21
EE02974B1 (et) 1997-04-15
BG99129A (bg) 1995-08-28
US5565455A (en) 1996-10-15
IL105449A0 (en) 1993-08-18
GR3032030T3 (en) 2000-03-31
JPH08503449A (ja) 1996-04-16

Similar Documents

Publication Publication Date Title
EP0538422B1 (en) New use of diphenylbutylpiperazinecarboxamides in the treatment of substance disorders
IE83379B1 (en) New use of diphenylbutylpiperazinecarboxamides in the treatment of substance abuse
BG62154B1 (bg) Средства за лечение на смущения, причинени от неправилнаупотреба на вещества
US6221858B1 (en) Pyridyl-and pyrimidyl-piperazines in the treatment of substance abuse disorders
KR100491027B1 (ko) 물질남용질환치료를위한피리딜-및피리미딜-피페라진
CZ27299A3 (cs) Způsob léčení bipolární afektivní poruchy
RO115725B1 (ro) Esteri ai acidului nicotinic, procedee de preparare, compozitie care ii contine, si metoda de tratament
MXPA98009265A (en) Piridil- and pyrimidil-piperazines in the treatment of disorders from the abuse of sustain
JPH07502517A (ja) 精神病の治療のためのアリールインドールの使用